Irritable bowel syndrome concept from the gut microbiom point of view
https://doi.org/10.22416/1382-4376-2016-6-120-123
Abstract
Aim of review. To present data on integration of nutritional pattern and intestinal microbiom spectrum, to estimate the role of each of the listed factors in development of irritable bowel syndrome (IBS) symp toms. Summary. In spite of the fact, that IBS is one of the most common gastrointestinal functional disease, etiol ogy of disease is substantially unknown. Among factors which promote IBS development specific features of the patient and environmental factors, first of all nutritional stereotype and dietary pattern are considered nowa days. These in turn exert direct impact on quantitative and qualitative spectrum of gastrointestinal microbiota which changes, as it was demonstrated in the recent original studies, is an integral part of IBS pathogenesis and is the cornerstone of symptom origin of this func tional disorder. Conclusion. Pattern of intestinal microbiome, nutrition al stereotype and dietary pattern should be taken into account at management of IBS and planning of clinical or pilot studies in this area.
About the Authors
Anna F. Sheptulina
Federal state educational government-financed institution of higher education «Sechenov First Moscow state medical university»
Russian Federation
Russian Federation
Vladimir T. Ivashkin
Federal state educational government-financed institution of higher education «Sechenov First Moscow state medical university»
Russian Federation
Russian Federation
References
1. Lovell R.M., Ford A.C. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10:712-21.
2. Rajilić-Stojanović M., Jonkers D.M., Salonen A., Hanevik K., Raes J., Jalanka J. et al. Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena? Am J Gastroenterol 2015; 110(2):278-87.
3. Jeffery I.B., O’Toole P.W., Öhman L., Claesson M.J., Deane J., Quigley E.M. et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 2012; 61:997-1006.
4. Rajilić-Stojanović M., Biagi E., Heilig H.G., Kajander K., Kekkonen R.A., Tims S. et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011; 141:1792-801.
5. Crouzet L., Gaultier E., Del’Homme C., Cartier C., Delmas E., Dapoigny M. et al. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 2013; 25: e272-e282.
6. De Palma G. Transfer of anxiety and gut dysfunction from IBS patients to gnotobiotic mice through microibota transplatation. CDDW 2014; 2014: A183.
7. Buhner S1, Li Q., Vignali S., Barbara G., De Giorgio R., Stanghellini V. et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009; 137(4):1425-34.
8. Monsbakken K.W., Vandvik P.O., Farup P.G. Perceived food intolerance in subjects with irritable bowel syndrome - etiology, prevalence and consequences. Eur J Clin Nutr 2006; 60:667-72.
Review
For citations:
Sheptulina A.F., Ivashkin V.T. Irritable bowel syndrome concept from the gut microbiom point of view. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2016;26(6):120-123. (In Russ.) https://doi.org/10.22416/1382-4376-2016-6-120-123
Views:
1091
Email this article 
